APA (7th ed.) Citation

Yang, C., Brezden-Masley, C., Joy, A. A., Sehdev, S., Modi, S., Simmons, C., & Henning, J. (2023, June). Targeting HER2-low in metastatic breast cancer: An evolving treatment paradigm. Therapeutic Advances in Medical Oncology.

Chicago Style (17th ed.) Citation

Yang, Charlie, Christine Brezden-Masley, Anil Abraham Joy, Sandeep Sehdev, Shanu Modi, Christine Simmons, and Jan-Willem Henning. "Targeting HER2-low in Metastatic Breast Cancer: An Evolving Treatment Paradigm." Therapeutic Advances in Medical Oncology Jun. 2023.

MLA (9th ed.) Citation

Yang, Charlie, et al. "Targeting HER2-low in Metastatic Breast Cancer: An Evolving Treatment Paradigm." Therapeutic Advances in Medical Oncology, Jun. 2023.